Antiretroviral Improvement Among Medicaid Enrollees
Reason given: Insufficient rate of accrual
Key facts
- Where
- Richmond, United StatesSee the site
Where in United States
- Virginia Commonwealth UniversityRichmond, United StatesNo longer taking part
Trial details
- Who runs it
- Virginia Commonwealth University
- Trial code
- NCT05477485
- Record updated
- 21 October 2025
- Original description
This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.Read full original descriptionShow less
Antiretroviral Improvement Among Medicaid Enrollees (AIMS): An Insurance-based Data to Care Initiative for Medicaid Enrollees in Virginia
This study will evaluate whether a new program will affect how often human immunodeficiency virus (HIV) antiretroviral therapy (ART) prescriptions are filled and whether the program improves the health of people living with HIV.
Inclusion: Current enrollment in Virginia Medicaid; Continuous Virginia Medicaid enrollment for the preceding 9 or more months; Current age 19-64 years; Identified as living with HIV according to an HIV case identification algorithm; Non-dual eligible for Medicare; History of ART prescription claim(s) within the past 12 months; Prior ART prescription claim, with claims for the most recent ART prescription refill(s) >30 days late.
Exclusion: New prescription claim(s) within 30 days for within-class ART drug(s) not previously prescribed; Service claim(s) for resistance testing and other ART prescription claim(s) within 30 days of most recent late ART prescription(s) for ART drug(s) not previously prescribed; Enrollee's linked HIV provider practices at a healthcare facility offering PositiveLinks; No record in the Virginia HIV surveillance data; Record of non-Medicaid health insurance or other health care service payer in past 3 months; Non-English speaking.